Showing results (261-270 of 408) with videos related to

Sort By:
Pageof 41
Head & Neck|February 21, 2022
Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancerHugh A J Kim, Peter Y F Zeng, Alana Sorgini, et al.
Cells|June 11, 2025
A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance-A Role for Nicotinamide N-MethyltransferaseJessica A Wright, Stephanie D White, Gavin Frame, et al.
Cell Reports. Medicine|May 16, 2026
Understanding and overcoming innate and acquired MAPK inhibition resistance in anaplastic thyroid cancerPeter Y F Zeng, Jalna Meens, Amir Hossein Karimi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2015
Integrating RAS status into prognostic signatures for adenocarcinomas of the lungMaud H W Starmans, Melania Pintilie, Michelle Chan-Seng-Yue, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2023
Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical TrialsJohn Nikitas, Wee Loon Ong, Nathalie Carrier, et al.
Nature Communications|June 13, 2024
Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomesAmanda Khoo, Meinusha Govindarajan, Zhuyu Qiu, et al.
Oncotarget|October 27, 2017
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancerFarhad Ghasemi, Morgan Black, Frederick Vizeacoumar, et al.
Nature Methods|May 19, 2015
Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detectionAdam D Ewing, Kathleen E Houlahan, Yin Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repairAlan Dal Pra, Emilie Lalonde, Jenna Sykes, et al.
Head & Neck|December 7, 2023
HPV-negative head and neck cancers with adverse pathological features carry specific molecular changes that are associated with survivalHugh Andrew Jinwook Kim, Peter Y F Zeng, Matthew Cecchini, et al.
Pageof 41